Patents Represented by Attorney Finnegan, Hednerson, Farabow, Garrett & Dunner
  • Patent number: 6919340
    Abstract: A novel composition comprises a compound of Formula 1 the pharmaceutically acceptable salts, hydrates, solvates, crystal forms, diastereomers, prodrugs, or mixtures thereof. The composition is of particular utility in the treatment of kinase-implicated disorders.
    Type: Grant
    Filed: April 21, 2003
    Date of Patent: July 19, 2005
    Assignee: Cellular Genomics, Inc.
    Inventors: Kevin S. Currie, Robert W. DeSimone, Douglas A. Pippin, James W. Darrow, Scott A. Mitchell